Search Results - "STERNBERG, D. W"
-
1
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)
Published in Leukemia (2005)“…We report the cloning of a novel PDGFRB fusion gene partner in a patient with a chronic myeloproliferative disorder characterized by t(5;14)(q33;q32), who…”
Get full text
Journal Article -
2
Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation
Published in Molecular and Cellular Biology (01-05-2001)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
3
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
Published in Annals of oncology (01-05-2024)“…Human epidermal growth factor receptor 3 (HER3) is broadly expressed in non-small-cell lung cancer (NSCLC) and is the target of patritumab deruxtecan…”
Get more information
Journal Article -
4
K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity
Published in The Journal of biological chemistry (05-01-1992)“…The rat pheochromocytoma PC12 cell line differentiates into a sympathetic neuronal phenotype upon treatment with either nerve growth factor (NGF) or basic…”
Get full text
Journal Article -
5
The Low-Affinity p75 Nerve Growth Factor (NGF) Receptor Mediates NGF- Induced Tyrosine Phosphorylation
Published in Proceedings of the National Academy of Sciences - PNAS (15-08-1991)“…Protein tyrosine phosphorylation is a potential mechanism for initial signaling in PC12 cells during differentiation in response to nerve growth factor (NGF)…”
Get full text
Journal Article -
6
Combination of Rapamycin and Protein Tyrosine Kinase (PTK) Inhibitors for the Treatment of Leukemias Caused by Oncogenic PTKs
Published in Proceedings of the National Academy of Sciences - PNAS (02-03-2004)“…Abnormal protein tyrosine kinases (PTKs) cause many human leukemias. For example, BCR/ABL causes chronic myelogenous leukemia (CML), whereas FLT3 mutations…”
Get full text
Journal Article -
7
Nerve Growth Factor Stimulates Protein Tyrosine Phosphorylation in PC-12 Pheochromocytoma Cells
Published in Proceedings of the National Academy of Sciences - PNAS (01-04-1991)“…The cellular actions of nerve growth factor (NGF) and epidermal growth factor (EGF) may be mediated by changes in protein phosphorylation. The tyrosine…”
Get full text
Journal Article -
8
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine : A pharmacologically based regimen
Published in Cancer (01-05-2000)“…Although chemotherapy can achieve a high rate of disease remission induction in patients with newly diagnosed acute myelogenous leukemia (AML), patients with…”
Get full text
Journal Article -
9
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor β gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)
Published in Blood (15-06-2001)“…The molecular cloning of the t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia (CML) is reported. Fluorescence in situ hybridization (FISH),…”
Get full text
Journal Article -
10
Activation of a histone H1 kinase by tyrosine phosphorylation in v‐src‐transformed fibroblasts
Published in The EMBO journal (01-01-1993)“…Using anti‐phosphotyrosine immunoaffinity chromatography, we have searched for serine/threonine kinases that are directly regulated by tyrosine phosphorylation…”
Get full text
Journal Article -
11
S-methyl glutathione synthesis is catalyzed by the cheR methyltransferase in Escherichia coli
Published in Journal of Bacteriology (01-03-1986)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
A phase I study evaluating the combination of OSI-906, a dual inhibitor of insulin growth factor-1 receptor (IGF-1R) and insulin receptor (IR) with weekly paclitaxel (PAC) in patients with advanced solid tumors
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
13
Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
Published in The Journal of experimental medicine (20-02-2006)“…Mutations constitutively activating FLT3 kinase are detected in approximately 30% of acute myelogenous leukemia (AML) patients and affect downstream pathways…”
Get full text
Journal Article -
14
Quantitative Proteomic Analysis Using Isobaric Protein Tags Enables Rapid Comparison of Changes in Transcript and Protein Levels in Transformed Cells
Published in Molecular & cellular proteomics (01-07-2005)“…Isobaric tags for relative and absolute quantitation, an approach to concurrent, relative quantification of proteins present in four cell preparations, have…”
Get full text
Journal Article -
15
NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a
Published in Blood (15-06-2004)“…Between 30% and 50% of patients with advanced-stage anaplastic large-cell lymphoma (ALCL) harbor the balanced chromosomal rearrangement t(2;5)(p23;q35), which…”
Get full text
Journal Article -
16
The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis
Published in Journal of clinical oncology (15-01-2004)“…Human leukemias are frequently associated with the aberrant expression of activated fusion tyrosine kinases or activated protein tyrosine kinases carrying…”
Get full text
Journal Article -
17
Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation
Published in Molecular and cellular biology (01-05-2001)“…TEL-JAK2 fusion proteins, which are a result of t(9; 12)(p24; p13) translocations associated with human leukemia, activate Stat5 in vitro and in vivo and cause…”
Get full text
Journal Article -
18
PD09-03: Phase I/II Study of BKM120 in Combination with Trastuzumab in Patients with HER2 Overexpressing Metastatic Breast Cancer Resistant to Trastuzumab-Containing Therapy
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Introduction: HER2 amplification can activate the phosphatidylinositol-3-kinase (PI3K) pathway in breast cancer. Furthermore, trastuzumab (T) resistance can be…”
Get full text
Journal Article -
19
Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges
Published in Current opinion in hematology (01-01-2005)“…PURPOSE OF REVIEWThe fms-like tyrosine kinase 3 (FLT3) receptor tyrosine kinase is now recognized to be a critical mediator in the pathogenesis of myeloid and…”
Get full text
Journal Article -
20
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways
Published in Blood (01-12-2001)“…The TEL/PDGFbetaR gene, which encodes a fusion protein containing the ETS-family member TEL fused to the protein-tyrosine kinase domain of the platelet-derived…”
Get full text
Journal Article